APA

Adams J. L., Garigipati R. S., Sorenson M., Schmidt S. J., Brian W. R., Newton J. F., Tyrrell K. A., Garver E., Yodis L. A., Chabot-Fletcher M., Tzimas M., Webb E. F., Breton J. J. & Griswold D. E. (19970124). Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea. : Journal of medicinal chemistry.

Chicago

Adams J L, Garigipati R S, Sorenson M, Schmidt S J, Brian W R, Newton J F, Tyrrell K A, Garver E, Yodis L A, Chabot-Fletcher M, Tzimas M, Webb E F, Breton J J and Griswold D E. 19970124. Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea. : Journal of medicinal chemistry.

Harvard

Adams J. L., Garigipati R. S., Sorenson M., Schmidt S. J., Brian W. R., Newton J. F., Tyrrell K. A., Garver E., Yodis L. A., Chabot-Fletcher M., Tzimas M., Webb E. F., Breton J. J. and Griswold D. E. (19970124). Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea. : Journal of medicinal chemistry.

MLA

Adams J L, Garigipati R S, Sorenson M, Schmidt S J, Brian W R, Newton J F, Tyrrell K A, Garver E, Yodis L A, Chabot-Fletcher M, Tzimas M, Webb E F, Breton J J and Griswold D E. Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea. : Journal of medicinal chemistry. 19970124.